Alpine Immune Sciences Investor Relations Material
Latest events
Study Update
Alpine Immune Sciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Alpine Immune Sciences Inc
Access all reports
Alpine Immune Sciences Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for autoimmune and inflammatory diseases, as well as cancer. The company uses its proprietary platform to engineer protein-based therapies that modulate the immune system to enhance treatment efficacy. Alpine's approach aims to create novel immunotherapies that target immune pathways, offering potential treatments for patients with unmet medical needs in areas such as immuno-oncology and autoimmune disorders. Its pipeline includes a range of drug candidates designed to address these conditions. The company is headquartered in Seattle, Washington, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
ALPN
Country
🇺🇸 United States